KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Return on Equity (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Return on Equity for 16 consecutive years, with 0.11% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 37.0% to 0.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.11%, a 37.0% increase, with the full-year FY2025 number at 0.11%, up 35.0% from a year prior.
  • Return on Equity was 0.11% for Q4 2025 at Bio-Rad Laboratories, up from 0.1% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.5% in Q3 2021 to a low of 0.69% in Q3 2022.
  • A 5-year average of 0.04% and a median of 0.04% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -119bps in 2022, then skyrocketed 67bps in 2023.
  • Bio-Rad Laboratories' Return on Equity stood at 0.29% in 2021, then tumbled by -237bps to 0.4% in 2022, then skyrocketed by 81bps to 0.07% in 2023, then crashed by -253bps to 0.26% in 2024, then surged by 141bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for BIO's Return on Equity are 0.11% (Q4 2025), 0.1% (Q3 2025), and 0.05% (Q2 2025).